Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    701 Bone Marrow Family Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 63
    702 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 68
    703 Bone Marrow Family Allogeneic Myelofibrosis Hematology 2025 Standard Therapy France 71
    704 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 51
    705 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
    706 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 54
    707 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 16
    708 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 61
    709 Bone Marrow Family Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 61
    710 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 70
    711 Bone Marrow Family Allogeneic PostET Myelofibrosis Hematology 2025 Standard Therapy Netherlands 21
    712 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 68
    713 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia/ Mielodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
    714 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 60
    715 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 33
    716 Bone Marrow Family Allogeneic Muscular Dystrophy Association Hematology 2025 Standard Therapy United Kingdom 75
    717 Bone Marrow Family Allogeneic Acute Myeloid Leukemia Hematology 2025 Standard Therapy Germany 72
    718 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 77
    719 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 23
    720 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 58
    721 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy United Kingdom 53
    722 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 75
    723 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 61
    724 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 8
    725 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    726 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 38
    727 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
    728 Bone Marrow Family Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 69
    729 Bone Marrow Family Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 31
    730 Bone Marrow Family Allogeneic Acute Myleogenous Leukemia, alloPBST 7/2025 Hematology 2025 Standard Therapy Germany 53
    731 Bone Marrow Allogeneic Aplastic Anemia Hematology 2025 Standard Therapy Spain 15
    732 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Norway 55
    733 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 3
    734 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 7
    735 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Ukraine 36
    736 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 10
    737 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 76
    738 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 39
    739 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy South Africa 6
    740 Bone Marrow Allogeneic Wiskott-Aldrich syndrome Hematology 2025 Standard Therapy Turkey 6
    741 Bone Marrow Allogeneic Combined immnunodeficiency Hematology 2025 Standard Therapy Ukraine 3 months
    742 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Poland 3
    743 Bone Marrow Allogeneic Mixed Phenotype Acute Leukemia Hematology 2025 Standard Therapy Poland 13
    744 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 7
    745 Bone Marrow Allogeneic B-cell precursor Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 56
    746 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 43
    747 Bone Marrow Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 19
    748 Bone Marrow Allogeneic Very Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 12
    749 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 5
    750 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 10 months
    751 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 6
    752 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 44
    753 Bone Marrow Allogeneic Paroxysmal Nocturnal Hemoglobinuria Hematology 2025 Standard Therapy Poland 25
    754 Bone Marrow Allogeneic Juvenile Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 4
    755 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 21
    756 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 12
    757 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Hungary 10
    758 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Czechia 68
    759 Bone Marrow Allogeneic Adrenoleukodystrophy Hematology 2025 Standard Therapy Poland 53
    760 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 4
    761 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy France 4
    762 Bone Marrow Allogeneic Paroxysmal Nocturnal Hemoglobinuria Hematology 2025 Standard Therapy Norway 18
    763 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Spain 24
    764 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Belarus 5
    765 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Germany 53
    766 Bone Marrow Allogeneic diamond-Balckfan anemia Hematology 2025 Standard Therapy Germany 11
    767 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 57
    768 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 61
    769 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy France 3
    770 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belarus 1
    771 Bone Marrow Allogeneic pB-Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 15
    772 Bone Marrow Allogeneic OHID XIAP – Other Histiocytic Disorders / X-Linked Inhibitor of Apoptosis Protein Hematology 2025 Standard Therapy Switzerland 2
    773 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 46
    774 Bone Marrow Allogeneic Acquired Idiopathic Sideroblastic Anemia Hematology 2025 Standard Therapy Russian Federation 5
    775 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 10
    776 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 47
    777 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy CROATIA 11
    778 Bone Marrow Allogeneic Juvenile myelomonocytic leukemia Hematology 2025 Standard Therapy Poland 5
    779 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Brazil 12
    780 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Australia 8
    781 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 3
    782 Bone Marrow Allogeneic Myelodysplatic Syndrome Hematology 2025 Standard Therapy USA 60
    783 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russia 36
    784 Bone Marrow Allogeneic Thalassemia major Hematology 2025 Standard Therapy Turkey 10
    785 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 58
    786 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Poland 2
    787 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 18
    788 Bone Marrow Allogeneic Other Non-Malignant Disease, Specify Hematology 2025 Standard Therapy USA 17
    789 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 15
    790 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 15
    791 Bone Marrow Allogeneic aplastic anemia Hematology 2025 Standard Therapy Belgium 36
    792 Bone Marrow Allogeneic Primary Refractory Hematology 2025 Standard Therapy Ireland 27
    793 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 39
    794 Bone Marrow Allogeneic Sickle Cell Disease (SCD) Hematology 2025 Standard Therapy Italy 8
    795 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 68
    796 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 58
    797 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 1
    798 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2025 Standard Therapy United Kingdom 13
    799 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 38
    800 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 17